Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BioNexus Gene Lab (BGLC) Non Operating Income (2024 - 2025)

BioNexus Gene Lab's Non Operating Income history spans 2 years, with the latest figure at $107760.0 for Q3 2025.

  • For Q3 2025, Non Operating Income fell 76.85% year-over-year to $107760.0; the TTM value through Sep 2025 reached $1.1 million, changed N/A, while the annual FY2024 figure was $2.1 million, 326.4% up from the prior year.
  • Non Operating Income for Q3 2025 was $107760.0 at BioNexus Gene Lab, down from $209461.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $730105.0 in Q2 2024 and bottomed at $91420.0 in Q1 2025.